Bioventus (NASDAQ:BVS) Shares Gap Up – Here’s Why

Bioventus Inc. (NASDAQ:BVS) gapped up prior to trading on Monday . The stock had previously closed at $8.51, but opened at $9.03. Bioventus shares last traded at $8.60, with a volume of 102,601 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Bioventus in a research report on Monday, December 29th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat, Bioventus presently has an average rating of “Hold”.

Bioventus Stock Performance

The company has a current ratio of 1.74, a quick ratio of 1.14 and a debt-to-equity ratio of 1.50. The stock’s 50 day moving average price is $7.70 and its two-hundred day moving average price is $7.26. The firm has a market capitalization of $705.94 million, a price-to-earnings ratio of 71.09 and a beta of 0.80.

About Bioventus

Bioventus, headquartered in Durham, North Carolina, is a global medical device company specializing in orthobiologic solutions aimed at accelerating healing and improving patient outcomes in musculoskeletal conditions. The company develops and commercializes a portfolio of non‐surgical therapies designed to address bone healing, osteoarthritis pain management and soft tissue repair. Its flagship EXOGEN® Ultrasound Bone Healing System utilizes low‐intensity pulsed ultrasound technology to stimulate bone growth and has been widely used in the management of delayed fractures and nonunions.